Researchers at the RIKEN Center for Developmental Biology will treat the first patient in its clinical trial testing an induced pluripotent stem cell-based treatment for age-related macular degeneration.
A technique that reversibly bundles tagged cargo into artificial membraneless compartments gives scientists the ability to switch cell processes on and off.
It's been hard to miss the recent antagonism between elements in the religious and scientific communities over issues such as evolution and the ethics of embryonic stem cell research.